Radioactive iodine therapy with recombinant human TSH (rhTSH) for well-differentiated thyroid cancer had no difference in GO outcome; case report
2014 ◽
Vol 37
(1)
◽
pp. 57-64
◽
2018 ◽
Vol 39
(12)
◽
pp. 1091-1096
◽
2016 ◽
Vol 44
(6)
◽
pp. 926-934
◽
2018 ◽
Vol 52
(4)
◽
pp. 287-292
◽
2019 ◽
Vol 47
(3)
◽
pp. 561-571
◽
2019 ◽
Vol Volume 11
◽
pp. 467-474
◽